Lucid Ret. sur les actifs
Quel est le Ret. sur les actifs de Lucid?
Le Ret. sur les actifs de Lucid, Inc. est -174.77%
Quelle est la définition de Ret. sur les actifs?
Le rendement des actifs indique dans quelle mesure les actifs d'une entreprise génèrent des revenus. Il est calculé en divisant le résultat net par l'actif total moyen.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. sur les actifs des entreprises dans Health Care secteur sur OTC par rapport à Lucid
Que fait Lucid?
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Entreprises avec ret. sur les actifs similaire à Lucid
- Hank Payments a Ret. sur les actifs de -178.17%
- Adveritas a Ret. sur les actifs de -177.51%
- Rhinomed a Ret. sur les actifs de -176.99%
- Mydecine Innovations a Ret. sur les actifs de -176.15%
- Achiko AG a Ret. sur les actifs de -175.93%
- Power Projects a Ret. sur les actifs de -174.85%
- Lucid a Ret. sur les actifs de -174.77%
- Biostage a Ret. sur les actifs de -174.42%
- Hepion Pharmaceuticals Inc a Ret. sur les actifs de -174.30%
- Bankers Cobalt Corp a Ret. sur les actifs de -174.28%
- LawFinance a Ret. sur les actifs de -174.20%
- Pathway Health Corp a Ret. sur les actifs de -173.40%
- Harvest Technology a Ret. sur les actifs de -172.87%